|
BioScreening - organic compounds for screening
Biotech & Pharma Business and Investment NewsChelsea Therapeutics Gains Global Rights to I-3D Portfolio Targeting Autoimmune Disease and Transplant Rejection - CHARLOTTE, N.C., April 8, 2008 (PRIME NEWSWIRE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has acquired full global rights to the I-3D portfolio of orally active, dihydroorotate dehydrogenase (DHODH) inhibiting compounds for the treatment of autoimmune diseases and transplant rejection.
Following a decision to focus its resources on its immunomodulatory compounds, Active Biotech AB [...]
Health Care’s Silent Spring - As the Intergovernmental Working Group (IGWG) of the WHO prepares to meet and discuss how to best facilitate the expropriation of intellectual property rights (in this case the IPR of pharmaceutical patents) it’s important to consider the unintended consequences — the death of medical innovation.
The global purloiners of patents — led by Jamie Love — [...]
Soon-to-be Laid Off Schering-Plough Employees - As reported in today’s Newark Star-Ledger, Schering-Plough’s New Jersey employees will bear the brunt of Fred Hassan’s plan to fire, terminate, let go with extreme prejudice, 5,500 people in S-P’s workforce:
“Schering-Plough’s chief executive said yesterday the budget ax will fall first and hardest in New Jersey as the drugmaker cuts more than $1 billion in [...]
Roche deal tests drug cardiotoxicity on unique lab platform - Roche has entered into an agreement to provide drug compounds for cardiotoxicity testing using a cell-based platform that could play a major role in the preclinical safety evaluation of drugs and newly developed compounds.
The deal aims to detect any drug-induced changes in the electrical activity of the heart, such as prolongation of the QT interval, [...]
Seaside Therapeutics Awards $4.5 Million Collaborative Research Contract to Vanderbilt University Medical Center - Seaside Therapeutics announced today the award of a $4.5 million collaborative research contract to Vanderbilt University Medical Center to discover novel compounds to potentially suppress the manifestations of fragile X syndrome. Fragile X syndrome [...]
Profiling of Tumor Tissue Slices is Awarded Prize - Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest
Rostock, Germany, November 26, 2007 / b3c newswire / - Bionas GmbH, a specialist for in vitro profiling the metabolic activity of cells, announced that Prof. Pedro Mestres of the Saarland University (Homburg/Saar, Germany) has been awarded [...]
Znomics, Inc. Completes $4.88 Million Financing and Merger With Public Company - PORTLAND, Ore., Nov. 27, 2007 (PRIME NEWSWIRE) — Znomics, Inc., a pioneer in the development of the zebrafish as a simple vertebrate genetic platform to accelerate drug discovery, announced the successful closing on November 5, 2007 of a $4.88 million private offering. Simultaneously with the close of the private offering, the company effected a merger [...]
Upstream Biosciences Launches Chemoinformatics Program to Extend Its Drug Discovery Capabilities - Upstream Biosciences Inc. (OTCBB: UPBS) today announced it is establishing a Chemoinformatics Program to extend its drug discovery efforts into additional disease areas. Upstream’s Chemoinformatics Program combines artificial intelligence, advanced computational methods and chemical diversity techniques that will be applied to the company’s proprietary drug scaffolds and compound library. This effort will initially build on [...]
BIOSERVE and DNAPRINT(R) GENOMICS FORM STRATEGIC ALLIANCE TO PROVIDE CLINICAL PATIENT SAMPLES TAGGED WITH GENETIC ANCESTRY DATA - BioServe’s fully annotated clinical samples across many diseases to be tagged with ancestry information using DNAPrint’s genetic ancestry tests
BELTSVILLE, MD., Oct. 9, 2007 – BioServe today announced the formation of strategic alliance with DNAPrint® Genomics, Inc. (OTCBB: DNAG) to provide biomedical researchers with clinical DNA samples that for the first time will include genetic ancestry [...]
Cellexus Biosystems appoints System C Industrie as its distributor in France - Cellexus Biosystems plc (PLUS Markets: CBIO), the specialist in the design, manufacture and commercialisation of novel disposable technology for growing cells, has entered into a distribution agreement with System C Industrie, France.
System C Industrie distributes an extensive range of instruments and applications for physico-chemical analysis and industrial bioreactors. The Company’s headquarters are located in the [...]
BioServe Signs Co-Distribution Deal with NeoCodex - Companies Gain Expanded Access to Human Tissue Samples Needed for Medical Research and Discovery
Â
Beltsville, MD, September 17, 2007 – Bioserve today bolstered its Global Repository® of tissue, DNA and serum samples with the announcement of a joint distribution deal with NeoCodex SL. Headquartered out of Seville, Spain, and dually focused [...]
Ambit Announces Update in Its Technology to Screen for Sources of Diseases - Nereus Pharmaceuticals Raises $45 Million in Private Placement
A Sorrento Valley company in the habit of selling screening services to big pharmaceutical concerns interested in seeing how various compounds react to select proteins has just announced a bigger, better screening technology.
Ambit Biosciences Chief Executive Officer Scott Salka said this month that its KinomeScan Profiling Technology can [...]
Hydra Lands Potential $195M Deal With Pfizer On Pain Drugs - Hydra Biosciences Inc. licensed rights to its TRPV3 antagonist program to Pfizer Inc. in a deal valued at up to $195 million.
The work centers around the relatively new area of transient receptor potential, or TRP, channels, which is distinct from traditional voltage gated ion channels. A number of companies have development programs targeting one of [...]
CLC bio funds further acceleration of bioinformatics product development - Aarhus, Denmark, July 3, 2007 — Today CLC bio, the world’s leading bioinformatics solution provider, announced that the company has entered an agreement, which ensures a significant amount of additional financing from local Danish private investors.
The group of private investors behind CLC bio has a capital base of more than 200 [...]
Evotec and Research Support International Limited Announce the Formation of Evotec-RSIL Ltd, a Joint Venture for the Design, Synthesis, Management and Commercialisation of Compound Libraries - HAMBURG, Germany and OXFORD, England, July 11, 2007 /PRNewswire-FirstCall/ — Evotec AG and Research Support International Limited (RSIL), a subsidiary of DIL Ltd, announced today the formation of a joint venture in India, Evotec-RSIL Ltd, to design, synthesise and manage compound libraries as a service. The joint venture will combine Evotec’s expertise in library design, [...]
The imminent change of the antithrombotics market - The antithrombotics market with the two blockbusters enoxaparin and prasugrel is challenged by generic products as well as by next generation anticoagulants with oral administration and antithrombotics with an improved risk-benefit ratio
Barcelona, Spain | May 30, 2007 | The Business Intelligence firm La Merie S.L. reported today that the US$ 9.6 bln market of the [...]
Amylin invests $10M in BioSeek - BioSeek, based in Burlingame, will work with San Diego-based Amylin (NASDAQ: AMLN) on treatments for inflammatory diseases. The work will put Amylin’s proprietary drug compounds through BioSeek’s biological screening systems to seek useful drugs. BioSeek can choose two peptide compounds after screening and develop them if it wishes, paying milestones and royalties to Amylin if [...]
A Promising Future? Pharmaprojects Reveals an Increase in Drug R&D for 2007 - LONDON, May 1 /PRNewswire/ — Pharmaprojects, the world’s leading source of business-critical intelligence on drugs in global R&D reveals that after a period of levelling off in recent years in the growth of the number of drugs in development, a new era of pipeline expansion may have begun. Pharmaprojects’ unique ‘Trends Search’ facility, which recently [...]
Canadian Cancer Society invests nearly $5-million in local researchers - VANCOUVER, May 2 /CNW/ - The Canadian Cancer Society has awarded more
than $4.8-million to nine cancer research projects in B.C.
The Society’s total research investment across Canada in 2007-08 is over
$47-million and includes 78 new grants. More than 500 research teams
coast-to-coast are currently receiving funds from the Canadian Cancer Society.
“Advances in research over the past few [...]
BioServe Acquires Genomics Collaborative - BioServe Extends Genomics Services Platform with Premier Industrial Biobank for Biomarker Discovery and Validation
Beltsville, MD, May 1st, 2007 – BioServe, a leading provider of genomics services, today announced that it has acquired Genomics Collaborative from SeraCare Life Sciences, Inc. Genomics Collaborative is a leader in facilitating biomarker discovery and validation through its Global Repository®, a [...]
|
|
